Article
Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention.
Pharmacogenetics and genomics - 1 Oct 2013
Park Mahn-Won, Her Sung Ho, Kim Ho-Sook, Choi Yun-Seok, Park Chul-Soo, Koh Yoon-Seok, Park Hun-Jun, Kim Pum-Joon, Kim Chan Joon, Jeon Doo Soo, Shin Dong Il, Seo Suk Min, Yoo Ki-Dong, Kim Dong Bin, Kim Hee Yeol, Lee Jong Min, Chung Wook-Sung, Seung Ki-Bae, Shin Jae-Gook, Chang Kiyuk
Abstract excerpt
The impact of the CYP2C19*17 polymorphism on the clinical outcome in Asians undergoing percutaneous coronary intervention (PCI) is unknown. We sought to assess the long-term impact of CYP2C19*17 on the risk for adverse clinical events in 2188 Korean patients taking clopidogrel after PCI. The prev...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
